$13.29
Value $2.0B
CC and ECL stock compared: price, dividend, valuation and results, from SEC filings.
$13.29
Value $2.0B
$309.27
Value $87.2B
Chemours (CC) has a market value of $2.0B and Ecolab (ECL) $87.2B. Over the last year, with dividends, CC moved +7.7% and ECL +19.8%. Dividend yield: CC 2.65%, ECL 0.94%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CC$2.0B
ECL$87.2B
ECL is 44 times CC
Revenue, 12 months
CC$5.8B
ECL$17.4B
ECL is 3.0 times CC
Net income, 12 months
CC-$154M
ECL$2.1B
Operating margin
CC–
ECL16.7%
ROIC
CC2.5%
ECL11.6%
9.1 points apart
P/E
CC–
ECL41.9
Dividend yield
CC2.7%
ECL0.9%
1.8 points apart
5-year return
CC-53.1%
ECL+38.8%
91.9 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CC-53.1%
ECL+38.8%
| Period | CCWith dividends | ECLWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +7.7%Price +5.4% | +19.8%Price +18.5% |
| 3 years since November 13, 2023 | -41.2%-16.2% a yearPrice -47.0% | +78.2%+21.2% a yearPrice +72.8% |
| 5 years since November 12, 2021 | -53.1%-14.0% a yearPrice -59.9% | +38.8%+6.8% a yearPrice +31.2% |
| 10 years since November 14, 2016 | -12.7%-1.4% a yearPrice -37.0% | +202.4%+11.7% a yearPrice +171.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CCChemoursECLEcolab
| Price | $13.29 | $309.27 |
|---|---|---|
| Market value | $2.0B | $87.2B |
| Enterprise value (EV) | $5.1B | $99.7B |
| P/E | – | 41.9 |
| P/E, 5-year median | 9.3 | 38.2 |
| P/B | 12.9 | 8.4 |
| EV/EBIT | 38.9 | 34.3 |
| Free cash flow yield | 10.6% | 2.1% |
| Revenue, 12 months | $5.8B | $17.4B |
|---|---|---|
| Net income, 12 months | -$154M | $2.1B |
| Free cash flow, 12 months | $211M | $1.8B |
| Earnings per share, 12 months | -$1.02 | $7.35 |
| Revenue growth, year on year | 0.4% | 2.2% |
| Revenue growth a year, past | +3.2%over 5 years | +6.4%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 15.1% | 43.9% |
|---|---|---|
| Operating margin | – | 16.7% |
| Net margin | -2.6% | 12.0% |
| ROIC | 2.5% | 11.6% |
| ROE | -91.1% | 20.8% |
| Cash | $698M | $722M |
|---|---|---|
| Total debt | $4.1B | $13.4B |
| Net debt / EBITDA | 6.6 | 3.5 |
| Interest cover | 0.5× | 7.4× |
| Dividend yield | 2.7% | 0.9% |
|---|---|---|
| Dividend per share, 12 months | $0.35 | $2.92 |
| Dividend growth a year, past | – | +7.2%over 5 years |
| Buyback yield | – | 0.9% |
| Shareholder yield | 2.7% | 1.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Ecolab ($87.2B) is about 43.7 times Chemours ($2.0B), at today's prices.
Since November 14, 2016, CC's price moved -37.0% and ECL's +171.3%. With dividends: CC -12.7% (-1.4% a year), ECL +202.4% (+11.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.65% for Chemours and 0.94% for Ecolab. Over the last twelve months they paid $0.35 and $2.92 per share.
Over the last twelve months, the net margin was -2.6% for Chemours and 12.0% for Ecolab, and the operating margin – and 16.7%. Revenue was $5.8B and $17.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.